Viewing Study NCT07224360


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2025-12-26 @ 2:25 AM
Study NCT ID: NCT07224360
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-04
First Post: 2025-10-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Sponsor: CSL Behring
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module